UC Berkeley Biochemist Jennifer Doudna Shares Nobel Prize for CRISPR Breakthrough
UC Berkeley's Jennifer Doudna and Emmanuelle Charpentier win the 2020 Nobel Prize in Chemistry for developing the revolutionary CRISPR-Cas9 gene-editing tool. The duo makes history as the first women to jointly win a Nobel Prize in the sciences.
UC Berkeley biochemist Jennifer Doudna wins the 2020 Nobel Prize in Chemistry, sharing the award with Emmanuelle Charpentier for their co-development of CRISPR-Cas9. This groundbreaking genome editing tool allows scientists to rewrite DNA in any organism, including human cells, with unprecedented efficiency and precision. The two researchers make history as the first women to win a Nobel Prize together in the sciences.
The versatility of CRISPR-Cas9 opens up wide-ranging possibilities across biology, agriculture, and medicine, including potential treatments for thousands of intractable diseases. Doudna emphasizes that what starts as a curiosity-driven, fundamental discovery project now serves as a breakthrough strategy used by countless researchers. She actively encourages continued support of fundamental science alongside public discourse about the ethical uses and responsible regulation of the technology.
Doudna and Charpentier share the 10 million Swedish krona prize, which exceeds $1 million. As a celebrated figure at UC Berkeley, Doudna credits the university's academic environment and leadership for allowing its faculty to thrive. Her historic achievement highlights the profound impact that collaborative, basic science research has on improving the human condition.